SCHEMBL13697649

SCHEMBL13697649

COC(=O)Cc1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.55
ALDH1A1 P00352 8/20 0.55
MAPT P10636 5/20 0.55
HPGD P15428 5/20 0.55
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
HSD17B10 Q99714 3/20 0.55
EGFR P00533 2/20 0.55
TSHR P16473 1/20 0.53
KIF11 P52732 2/20 0.51
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
HCRTR1 O43613 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PARP1 P09874 1/20 0.51
GAA P10253 2/20 0.50
GABRP O00591 1/20 0.50
GABRD O14764 1/20 0.50
PDE5A O76074 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24439539 0.91 ALDH1A1 (0.67) KDM4EALDH1A1MAPTHPGDHSD17B10
Methane SCHEMBL28732838 0.90 ALDH1A1 (0.65) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL31324202 0.85 ALDH1A1 (0.55) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL31324166 0.84 ALDH1A1 (0.54) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL31324221 0.84 MAPT (0.54) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL31324177 0.84 ALDH1A1 (0.54) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL31324183 0.84 KDM4E (0.60) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL31324178 0.83 MAPT (0.50) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL31324185 0.81 KDM4E (0.83) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL18938363 0.81 KDM4E (0.83) KDM4EALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743082-A1 CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION UCL Business Ltd (GB) 2026-05-20 EP disclosed
WO-2025012634-A1 CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION UCL BUSINESS LTD (GB) 2025-01-16 WO disclosed
US-20090227619-A1 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo XINJIANG HUASHIDAN PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227619-A1 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo TPH1, HTR1F, TPH2 KDM4E 2869/4885ALDH1A1 324/4885MAPT 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.